Matches in SemOpenAlex for { <https://semopenalex.org/work/W3153739594> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W3153739594 endingPage "68" @default.
- W3153739594 startingPage "62" @default.
- W3153739594 abstract "Abstract Objectives The treatment of acute herpangina is inconsistent. We aim to evaluate the effectiveness and safety of interferon α-2b spray versus Ribavirin for this disease. Methods A randomized, controlled trial was conducted in eight hospitals in China between 2016 and 2018. 668 patients (1–7 years old) were randomized into an experimental group (treated with Interferon α-2b spray) or control group (received Ribavirin Aerosol). Body temperature returning to normal within 72 h and remaining so for 24 h was the primary outcome; release of oral herpes and adverse events were the secondary outcomes. Results (1) The average age of onset was 2.5 years old. (2) After 72 h treatment, body temperature of 98.5% patients in experimental group and 94.3% in control group returned to normal and remained so for 24 h (P = 0.004). The differences were greater at 48 h treatment (95.2% vs. 85.9%, P Conclusions Local application of recombinant interferon α-2b spray showed better efficacy for acute herpangina in children. It was safe for use." @default.
- W3153739594 created "2021-04-26" @default.
- W3153739594 creator A5006900597 @default.
- W3153739594 creator A5013764005 @default.
- W3153739594 creator A5018281962 @default.
- W3153739594 creator A5020228349 @default.
- W3153739594 creator A5027386872 @default.
- W3153739594 creator A5033404835 @default.
- W3153739594 creator A5037458498 @default.
- W3153739594 creator A5037512011 @default.
- W3153739594 creator A5037672042 @default.
- W3153739594 creator A5056813172 @default.
- W3153739594 creator A5065745303 @default.
- W3153739594 creator A5067988551 @default.
- W3153739594 creator A5072911367 @default.
- W3153739594 creator A5073510459 @default.
- W3153739594 creator A5080311117 @default.
- W3153739594 creator A5080586769 @default.
- W3153739594 creator A5091535737 @default.
- W3153739594 creator A5091610908 @default.
- W3153739594 date "2021-06-01" @default.
- W3153739594 modified "2023-10-18" @default.
- W3153739594 title "Efficacy and safety of interferon α-2b spray for herpangina in children: A randomized, controlled trial" @default.
- W3153739594 cites W1977361887 @default.
- W3153739594 cites W2018380716 @default.
- W3153739594 cites W2046310800 @default.
- W3153739594 cites W2078789679 @default.
- W3153739594 cites W2087564721 @default.
- W3153739594 cites W2091674405 @default.
- W3153739594 cites W2097980864 @default.
- W3153739594 cites W2108788265 @default.
- W3153739594 cites W2518529437 @default.
- W3153739594 cites W2522973524 @default.
- W3153739594 cites W2534874190 @default.
- W3153739594 cites W2536325720 @default.
- W3153739594 cites W2588185991 @default.
- W3153739594 cites W2892110658 @default.
- W3153739594 cites W2899586934 @default.
- W3153739594 cites W2922114661 @default.
- W3153739594 cites W2958217124 @default.
- W3153739594 cites W2963409821 @default.
- W3153739594 cites W4253596390 @default.
- W3153739594 doi "https://doi.org/10.1016/j.ijid.2021.04.049" @default.
- W3153739594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33878461" @default.
- W3153739594 hasPublicationYear "2021" @default.
- W3153739594 type Work @default.
- W3153739594 sameAs 3153739594 @default.
- W3153739594 citedByCount "2" @default.
- W3153739594 countsByYear W31537395942023 @default.
- W3153739594 crossrefType "journal-article" @default.
- W3153739594 hasAuthorship W3153739594A5006900597 @default.
- W3153739594 hasAuthorship W3153739594A5013764005 @default.
- W3153739594 hasAuthorship W3153739594A5018281962 @default.
- W3153739594 hasAuthorship W3153739594A5020228349 @default.
- W3153739594 hasAuthorship W3153739594A5027386872 @default.
- W3153739594 hasAuthorship W3153739594A5033404835 @default.
- W3153739594 hasAuthorship W3153739594A5037458498 @default.
- W3153739594 hasAuthorship W3153739594A5037512011 @default.
- W3153739594 hasAuthorship W3153739594A5037672042 @default.
- W3153739594 hasAuthorship W3153739594A5056813172 @default.
- W3153739594 hasAuthorship W3153739594A5065745303 @default.
- W3153739594 hasAuthorship W3153739594A5067988551 @default.
- W3153739594 hasAuthorship W3153739594A5072911367 @default.
- W3153739594 hasAuthorship W3153739594A5073510459 @default.
- W3153739594 hasAuthorship W3153739594A5080311117 @default.
- W3153739594 hasAuthorship W3153739594A5080586769 @default.
- W3153739594 hasAuthorship W3153739594A5091535737 @default.
- W3153739594 hasAuthorship W3153739594A5091610908 @default.
- W3153739594 hasBestOaLocation W31537395941 @default.
- W3153739594 hasConcept C126322002 @default.
- W3153739594 hasConcept C168563851 @default.
- W3153739594 hasConcept C187212893 @default.
- W3153739594 hasConcept C71924100 @default.
- W3153739594 hasConceptScore W3153739594C126322002 @default.
- W3153739594 hasConceptScore W3153739594C168563851 @default.
- W3153739594 hasConceptScore W3153739594C187212893 @default.
- W3153739594 hasConceptScore W3153739594C71924100 @default.
- W3153739594 hasLocation W31537395941 @default.
- W3153739594 hasOpenAccess W3153739594 @default.
- W3153739594 hasPrimaryLocation W31537395941 @default.
- W3153739594 hasRelatedWork W1983073743 @default.
- W3153739594 hasRelatedWork W2235574018 @default.
- W3153739594 hasRelatedWork W2507295142 @default.
- W3153739594 hasRelatedWork W2953633878 @default.
- W3153739594 hasRelatedWork W3151010708 @default.
- W3153739594 hasRelatedWork W3159250744 @default.
- W3153739594 hasRelatedWork W3195440323 @default.
- W3153739594 hasRelatedWork W4256514411 @default.
- W3153739594 hasRelatedWork W4292236216 @default.
- W3153739594 hasRelatedWork W2083697902 @default.
- W3153739594 hasVolume "107" @default.
- W3153739594 isParatext "false" @default.
- W3153739594 isRetracted "false" @default.
- W3153739594 magId "3153739594" @default.
- W3153739594 workType "article" @default.